Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNYNF crawled date : 2021 - 10 - 26 save search
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Published: 2021-10-26 (Crawled : 23:00) - globenewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.39%
H: 0.23%
C: -1.13%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -0.4%
H: 1.16%
C: -5.35%
covid fda children vaccine merge emergency use authorization
Benuvia Manufacturing Appoints Scott Aladeen as Chief Operating Officer
Published: 2021-10-26 (Crawled : 15:15) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer
Published: 2021-10-26 (Crawled : 14:15) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
pharma
Amylyx Pharmaceuticals Hires Stéphanie Hoffmann-Gendebien, MBA, as Head, General Manager EMEA
Published: 2021-10-26 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
Published: 2021-10-26 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
UNCY | $1.09 100K
|
Professional, Scientific, and T...
|
| O: 7.11%
H: 5.17%
C: 1.85%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.2%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
Provention Bio Announces Positive Interim Results from First-In-Human Study of Coxsackievirus B Vaccine Candidate PRV-101
Published: 2021-10-26 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
positive results vaccine coxsackievirus prv-101
Tal Zaks Joins Strategic Advisory Board at Deep Genomics
Published: 2021-10-26 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
genomic
Innate Pharma 2022 Financial Calendar
Published: 2021-10-26 (Crawled : 10:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 4.1%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
NVO | $123.01 0.21% 2.6M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
IPHA | $2.35 3.6K
|
Health Technology
|
| O: 4.17%
H: 3.45%
C: 2.91%
pharma
Evotec Provides Preliminary Nine Month Financial Results
Published: 2021-10-26 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
financial results results
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.